Schonfeld Strategic Advisors LLC Reviva Pharmaceuticals Holdings, Inc. Call Options Transaction History
Schonfeld Strategic Advisors LLC
- $13.8 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RVPH
# of Institutions
40Shares Held
9.97MCall Options Held
133KPut Options Held
43.9K-
Armistice Capital, LLC New York, NY3.19MShares$5.86 Million0.08% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.83MShares$3.37 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$1.89 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA685KShares$1.26 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT512KShares$942,4510.1% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $37.6M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...